<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A91E8E72-1FFF-4144-BB77-220E470544E1"><gtr:id>A91E8E72-1FFF-4144-BB77-220E470544E1</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Stewart</gtr:otherNames><gtr:surname>Fife</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FI%2F00001712"><gtr:id>4F9B41AC-64E3-4314-BA6C-908549A78CC5</gtr:id><gtr:title>Molecular and genetic determinants of virus-host interactions affecting pathogenicity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/I/00001712</gtr:grantReference><gtr:abstractText>IAH has a distinct genetic resource of a number of inbred lines of chickens, which differ in their susceptibility to avian viral diseases. The availability of SNP (single nucleotide polymorphism) and CNV (copy number variation) data highlighting the genetic differences and the recent progress in the determination and the analysis of the data from re-sequencing of the genomes of these lines will enable us to make significant progress in understanding the molecular basis for the genetic differences that account for disease susceptibility. The Genetics and Genomics group will undertake detailed genetic analysis of the genomes of these unique lines to identify the determinants that are linked to disease resistance.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>1082979</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>SANGER IFITM</gtr:description><gtr:id>C7628C24-42A0-4818-863D-9A4167F290EE</gtr:id><gtr:impact>S. Smith, M. S. Gibson, R. Wash, F. Ferrara, E. Wright, N. Temperton, P. Kellam, and M. Fife. (2013) Chicken IFITM3 restricts Influenza viruses and Lyssaviruses in vitro. J. Virology. 87, 12957

Benfield C, Smith SE, Wright E, Wash RS, Ferrara F, Temperton NJ, Kellam P. Bat and pig Interferon-Induced Transmembrane Protein 3 restrict cell entry by influenza virus and lyssaviruses. J Gen Virol. 2015 (in press)</gtr:impact><gtr:outcomeId>56bdca4921e119.41946775-1</gtr:outcomeId><gtr:partnerContribution>Wellcome Trust Sanger Institute (WTSI) is a world leader in uncovering the genetic basis of disease including infectious disease, providing results that are translated into diagnostics, treatments or therapies that reduce global health burdens. The virus genomics group investigates human pathogenic virus infections and the molecular genetic determinants of disease pathogenesis and transmission including zoonotic virus infections.</gtr:partnerContribution><gtr:piContribution>The Pirbright Institute (TPI) is a world leader in research on viral diseases of livestock with a strong track record in translating this research into effective disease control. The Genetics and Genomics group is interested in understanding the genetics and evolution of animal-pathogen interactions, with the strategic aim of improving the control of viral disease outbreaks. The group's main focus involves the study of the genetic basis of avian viral disease resistance. The virus-restricting IFITM proteins are under investigation in this study, thus contributing directly to the BBSRC key strategic priority on Global Food security.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Roslin</gtr:description><gtr:id>CD2200BF-0D44-4DCA-ADCF-0B6DECAE6797</gtr:id><gtr:impact>SAL1 Patent for Salmonella resistance in chickens&amp;quot;-. PCT/GB2010/000850. The Pirbright Institute.</gtr:impact><gtr:outcomeId>56bdf0e78f7c41.20232078-1</gtr:outcomeId><gtr:partnerContribution>Poultry are a key reservoir of human Salmonella infections owing to the ability of some strains to colonise the avian
intestines and reproductive tract. Birds often carry the bacteria in the absence of overt symptoms; however some types of
Salmonella cause severe typhoid-like diseases in poultry that exert substantial welfare and economic costs. Global
population growth and rising affluence are fuelling demand for poultry meat and eggs, and a need exists to enhance the
supply and safety of such. Though vaccines are used in layers in some countries, most of the 55 billion chickens reared
annually worldwide lack protection against Salmonella infection. We and others have discovered that some chickens exhibit
heritable differences in resistance to Salmonella. It may be feasible to selectively breed for birds with improved resilience to
Salmonella infection; however this requires the identification of resistance-associated factors and knowledge of how they
act.
By analysing the genetic material of birds that differ in resistance, we have located a region of the chicken chromosome
that confers protection against typhoidal salmonellosis, both in laboratory studies and commercial poultry populations.
Recent studies have now resolved the region associated with resistance to just a handful of genes. It is highly plausible that
variation affecting two genes in this region (AKT1 and SIVA1) explains why birds react to Salmonella in different ways, as
the encoded proteins control host processes that impact on the fate of bacteria. For example, AKT1 and SIVA1 control the
death of infected cells and the induction of immune responses, but have opposing activities. It is not possible for us to
predict how the genetic changes affecting these genes will alter their expression or activity. Moreover, it is unclear how
such factors may control the growth and spread of Salmonella in birds. We therefore propose to:
1. Examine if birds normally respond to Salmonella infection by activating the expression or function of AKT1 and SIVA1.
We will examine this in cells cultured from chickens, as well as in intact birds, and associate any differences with host
responses and the fate of the bacteria.
2. Examine if lines of chicken known to differ in resistance to Salmonella infection vary in the levels or activation of AKT1
and SIVA1.
3. Use specific inhibitors and bacterial strains to establish that AKT1 activation is necessary for Salmonella to grow and
spread in birds.
4. Define the nature, frequency and consequences of genetic changes affecting AKT1 and SIVA1 in commercial poultry
populations. This will aid the selective breeding of chickens that show improved resilience to Salmonella infection.
We are fortunate to have the support of one of the world's largest poultry breeding companies (Erich Wesjohann Group),
who will provide birds, genome sequences, expertise and 10% of total project costs. This reflects the value of the proposed
studies to the industry. The consortium has productively collaborated and the proposed studies are a timely, logical and
feasible extension of our recent joint research.</gtr:partnerContribution><gtr:piContribution>Joint Grant: 'Role of AKT1 &amp;amp; SIVA1 in resistance to avian salmonellosis'
Stevens, Kaiser &amp;amp; Fife</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MF STEM2</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3F074987-5992-477B-A681-C40E8FFE954E</gtr:id><gtr:impact>1200 students from Years 9-13 i.e. pre- and in sixth form. Our exhibits included Vero cells in flasks, plaques, Vero cells viewed down a microscope, 2D real-size models of sequencing kit, virus and DNA models, careers hand-outs.</gtr:impact><gtr:outcomeId>56bdd51d89ff60.01455307</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MF STEM1</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C41EFEE4-6025-436C-83B1-97218D0A20D3</gtr:id><gtr:impact>'What's My Job?' careers education session on being a BBSRC research scientist. Well received and good interaction.</gtr:impact><gtr:outcomeId>56bdd4b80e9681.83038038</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AB Improving Approaches to Prevent and Control Viral Diseases of Livestock and Poultry</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C8F2CF22-9027-4757-A2C2-1BAC34D51383</gtr:id><gtr:impact>Batra, A., Maier, H.J., Britton P., Hiscox, J.A., Fife, M.S., 2015. PI3K/AKT signalling during infectious bronchitis virus infection. Food Security: Improving Approaches to Prevent and Control Viral Diseases of Livestock and Poultry, British Council Research Links Workshop, Istanbul, Turkey (Oral presentation)</gtr:impact><gtr:outcomeId>56bdd025f37970.55122940</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AB International Nidovirus Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BECEA4C8-AE68-4F88-9D8C-F128FB4C2CF0</gtr:id><gtr:impact>Batra, A., Maier, H.J., Britton P., Hiscox, J.A., Fife, M.S., 2014. AKT activation during infectious bronchitis virus infection. XIIIth International Nidovirus Symposium, Salamanca, Spain (Poster presentation)</gtr:impact><gtr:outcomeId>56bdceaf9ee2f6.75745358</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TW ARC</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FFB25744-494C-4E58-AA00-4DC05E8E8DDE</gtr:id><gtr:impact>ARC will hold up to two dissemination events per annum. The aim of these events is to facilitate the dissemination of the research findings from the grants awarded through ARC to the Industry Members of the Club and other researchers. The dissemination events also provide an excellent opportunity for networking and we encourage delegates to make the most of the time made available for this purpose in the programme. BBSRC staff and the ARC coordinators will be available throughout the day should you have any questions regarding the Club.
Presentations: The presentations are the main opportunity for ARC research groups to present research findings and future plans and for Industrial Members to find out about ARC funded projects and provide feedback. Featured projects have been allocated presentation time as described in the programme and should include at least 5 minutes for questions. Presenters are asked to keep to time and presentations should demonstrate the relevance of the work to animal health and the livestock industry.
Posters: Research groups funded through ARC have been offered the opportunity to provide posters of work which is of relevance to the Industry Members of the Club. This will provide an opportunity to have informal discussions about current progress during networking activities and provide additional project information of relevance to ARC.</gtr:impact><gtr:outcomeId>56bdd1c44734b6.22486497</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NL Animal Health Research Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C23861F9-1D00-4BD9-A50C-2FD08FFD34AC</gtr:id><gtr:impact>ARC will hold up to two dissemination events per annum. The aim of these events is to facilitate the dissemination of the research findings from the grants awarded through ARC to the Industry Members of the Club and other researchers. The dissemination events also provide an excellent opportunity for networking and we encourage delegates to make the most of the time made available for this purpose in the programme. BBSRC staff and the ARC coordinators will be available throughout the day should you have any questions regarding the Club.
Presentations: The presentations are the main opportunity for ARC research groups to present research findings and future plans and for Industrial Members to find out about ARC funded projects and provide feedback. Featured projects have been allocated presentation time as described in the programme and should include at least 5 minutes for questions. Presenters are asked to keep to time and presentations should demonstrate the relevance of the work to animal health and the livestock industry.
Posters: Research groups funded through ARC have been offered the opportunity to provide posters of work which is of relevance to the Industry Members of the Club. This will provide an opportunity to have informal discussions about current progress during networking activities and provide additional project information of relevance to ARC.</gtr:impact><gtr:outcomeId>56bdcfc2e91371.92641260</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TW Oxford Interdisciplinary Bioscience Networking Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32AA7934-CC68-4DC0-9AAF-9A9397B115E4</gtr:id><gtr:impact>Oxford Interdisciplinary Bioscience Networking Event</gtr:impact><gtr:outcomeId>56bdd200ef1104.99683730</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NL Transcriptomics Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CF6C8DE2-C8F5-4B6E-99BB-E9398174EB61</gtr:id><gtr:impact>2nd Transcriptomics Workshop, The Jenner Institute. Oxford, UK. 08/05/2015</gtr:impact><gtr:outcomeId>56bdd0b01ebb70.66483505</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NL Next Generation Sequencing applications to improve livestock welfare, food security and socioeconomic stability in Brazil, British research Council, Newton Fund</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D1FFEFCB-4785-43BF-B166-EF860BDEA6FF</gtr:id><gtr:impact>Presentation: Next Generation Sequencing applications to improve livestock welfare, food security and socioeconomic stability in Brazil, British research Council, Newton Fund</gtr:impact><gtr:outcomeId>56bdd10a012b31.00730915</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MF STEM3</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C60689F6-C5F9-4003-A771-5747FDF56502</gtr:id><gtr:impact>Students from Years 5-6 i. Gave a talk on the Ebola virus outbreak in west Africa. Porvided virus and DNA models, careers hand-outs.</gtr:impact><gtr:outcomeId>56bdd69c7d3154.48927426</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Innovate Guildford Outreach (12th March)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0DE133FC-7D5C-41C0-829B-69FE909AC41E</gtr:id><gtr:impact>Innovate Guildford Outreach (12th March).</gtr:impact><gtr:outcomeId>58b91c8add57b1.66937976</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Innovate Guildford Outreach (12th March)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>83A7A864-8ACF-4827-A2A9-6A8F2788A42C</gtr:id><gtr:impact>With amazing exhibits, activities, workshops, talks and competitions, it's FREE to attend. Explore the four zones: Engineering, One Health, Digital Media and Future Living, experience interactive performances, hear inspiring speakers (including leading gaming pioneer Peter Molyneux and animal health pioneer Professor Nick Bacon) and take in an amazing atmosphere. Theatre, music and comedy will feature through the day, with everything from how technology might have affected Shakespeare's plays to risky recycling and photographic secrets.</gtr:impact><gtr:outcomeId>58bd8b9489c942.39782498</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.guildford.gov.uk/innovateguildford</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Research on this project resulted in funding of an additional grant &amp;quot;interferon-inducible transmembrane proteins (IFITMs) Knock-Out for vaccine production.</gtr:description><gtr:id>231DE9D1-6A1B-406D-8C16-22D1D1671487</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5460a54d7f61b2.65335860</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Viral resistance genes (IFITM genes) in chickens: potential for increased vaccine produciton.</gtr:description><gtr:grantRef>BBS/E/I/00001712</gtr:grantRef><gtr:id>A668E922-5E27-4677-BBAC-FE8D12123AF6</gtr:id><gtr:impact>Viral resistance genes (IFITM genes) in chickens: potential for increased vaccine produciton.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56bde5e3d5ae39.53895458</gtr:outcomeId><gtr:patentId>PCT/GB2014/051693</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Viral resistance genes (IFITM genes) in chickens</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>SAL1 Patent for Salmonella resistance in chickens</gtr:description><gtr:grantRef>BBS/E/I/00001712</gtr:grantRef><gtr:id>0E6172EF-EBB8-4C81-864E-8DA473C28610</gtr:id><gtr:impact>Secured further funding and allowed Link grant with commercial company.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56bde5800ef516.71673337</gtr:outcomeId><gtr:patentId>PCT/GB2010/000850</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>SAL1 Patent for Salmonella resistance in chickens</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Type I interferons protect cells from virus infection through the induction of a group of genes collectively named interferon-stimulated genes (ISGs). Among these interferon stimulated proteins, are the IFITM (interferon-inducible transmembrane) genes which have been shown to restrict the replication of several highly pathogenic human viruses, including severe acute respiratory syndrome (SARS) coronavirus, filoviruses (Marburg virus and Ebola virus), influenza A viruses (IAVs), and flaviviruses (dengue virus). The Genetics and Genomics group have identified these antiviral proteins in the chicken (chIFITM) and have shown that a reduction in chIFITM expression results in an increase in the virus titre in CEFs infected with avian influenza A virus (AIV) H9N2, suggesting that chIFITMs have a functional role in the control of viral infections. The observation may have useful implications in terms of vaccine production. To this end, a patent was filed relating to the modification and testing of avian IFITMs, and has now been granted in multiple countries. Many vaccines have been produced in embryonated hen's eggs or continuous avian cell lines for more than 30 years. However, it is well established that the rate determining step in the manufacture of numerous vaccines is the induction of antiviral immune responses that prevents the replication of vaccine viruses. To generate chIFITM knock-down, we will use cutting edge genetic approaches such as siRNA and a CRISPR/Cas9 system which will directly target and knock-out chIFITM expression. We believe that this approach will overcome the rate limiting step in vaccine production, directly resulting in increased vaccine yields and improve the speed at which vaccines can be manufactured. We are currently in talks with major vaccine producers keen to adopt this internationally patented technology, to advance the field of both animal and human vaccine production.</gtr:description><gtr:grantRef>BBS/E/I/00001712</gtr:grantRef><gtr:id>78076F82-3BE2-46CA-A6F4-5DA61C3CF4CD</gtr:id><gtr:impact>This work has arisen as a result of an Animal Health Research Club grant. Involvement of the commercial sector has been encouraged and applauded by the ARC Steering committee. The IMPACT of this work is potentially very significant, and could provide considerable income to The Pirbright Institute.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>584aa335b46c95.46503793</gtr:outcomeId><gtr:patentId>United States Patent Application No. 14/895,866</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Avian cells for improved virus production</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Molecular and genetic determinants of virus-host interactions affecting pathogenicity has allowed research to be conducted on chicken disease resisitance and has resulted in the external fudning of the project entittled Restriction of avian viruses by host interferon-inducible transmembrane proteins (IFITMs).</gtr:description><gtr:exploitationPathways>This project is ongoing and is providing useful information of the activation of host gens by avian viruses.</gtr:exploitationPathways><gtr:id>81110D69-7CB1-460A-9C1F-FF9FC0039A4A</gtr:id><gtr:outcomeId>54609f0f4b00a1.17969064</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.pirbright.ac.uk/research/GeneticsGenomics/Default.aspx</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Development of a high density 600K SNP genotyping array for chicken.</gtr:description><gtr:id>1BE633C1-71A4-4B58-8A42-8F263BCF2C98</gtr:id><gtr:impact>Publication: Kranis A, Almas A Gheyas, Boschiero C, Turner F, Yu L, Smith S, Talbot R, Pirani A, Brew F, Kaiser P, Hocking P, Fife M et al. Development of a high density 600K SNP genotyping array for chicken. (2013) BMC Genomics, 14:59</gtr:impact><gtr:outcomeId>56bde4e355bf72.58224976</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Avian 600k SNP Array</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have established that chickens encode interferon-inducible transmembrane (IFITM) orthologues that restrict influenza infection in vitro. The aim of our work is to determine the biology and genetic variation of the IFITM locus in chickens, specifically the ability of IFITM genes and alleles to protect the host against both endemic and emerging avian viruses. The output of this project is to identify alleles that correlate with resistance to a number of avian viruses allowing poultry breeding programs to select the beneficial alleles. We have now produced contiguos sequnce for the IFITM Locus that was previously not represented in the Gallus gallus genome.</gtr:description><gtr:id>226EA7DA-2658-4A95-82DC-DB5BC9C08A65</gtr:id><gtr:impact>We have filed patents for the develpment of vaccines. Patent filed for The Pirbright &amp;amp; Sanger Institutes &amp;quot;Viral resistance genes (IFITM genes) in chickens&amp;quot;.
International Patent Application No. PCT/GB2014/051693.</gtr:impact><gtr:outcomeId>56bde3395ca1e7.03654494</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IFITM Seq</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>SAL1 Patent for Salmonella resistance in chickens&amp;quot;-. PCT/GB2010/000850. The Pirbright Institute.</gtr:description><gtr:id>3310093C-4064-406E-98B2-96F6C5416C3C</gtr:id><gtr:impact>SAL1 Patent for Salmonella resistance in chickens&amp;quot;-. PCT/GB2010/000850. The Pirbright Institute.</gtr:impact><gtr:outcomeId>56bde4161ee937.13558570</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SAL Locus</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Quantitative real-time PCR assays are widely used for the quantification of mRNA within avian experimental samples. Multiple stably-expressed reference genes can be used to control random technical variation between samples. It is necessary to select reference genes with the lowest variation in representative samples. The candidate reference gene assays must be reliable. In particular, they should have high amplification specificity and efficiency, and not produce signals from contaminating DNA. Whilst recent research papers identify specific genes that are stable in particular tissues and experimental treatments, here we describe a panel of ten avian gene primer and probe sets that can be used to identify suitable reference genes in many experimental contexts. The panel was tested with TaqMan and SYBR Green systems in two experimental scenarios, a tissue collection, and virus infection of cultured fibroblasts. GeNorm and NormFinder algorithms were able to select appropriate reference gene sets in each case. We show the effects of using the selected genes on the detection of statistically significant differences in expression. The results are compared with those obtained using 28s ribosomal RNA, the present most widely accepted reference gene in chicken work, identifying circumstances where the use of this gene might provide misleading results.
Widely used methods for eliminating DNA contamination of RNA reduced, but did not completely remove, detectable DNA. We therefore attached special importance to testing each qPCR assay for absence of signal using DNA template.</gtr:description><gtr:id>F2F87B8E-A91D-4E0B-95D4-2E6E0719F127</gtr:id><gtr:impact>The assays and analyses developed here provide a useful resource for selecting reference genes for investigations of avian biology.</gtr:impact><gtr:outcomeId>58bd8d8d814b83.18266752</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A Versatile Panel of Reference Gene Assays for the Measurement of Chicken mRNA by Quantitative PCR</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C579574F-F051-4AB7-B33C-8DC6F003B920</gtr:id><gtr:title>Identification, cloning, and functional characterization of the IL-1 receptor antagonist in the chicken reveal important differences between the chicken and mammals.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd522259e84925019b4209a0b5f48c7"><gtr:id>3dd522259e84925019b4209a0b5f48c7</gtr:id><gtr:otherNames>Gibson MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56b3807a1d3947.93189309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>214B249B-6FD5-47D9-861E-90C16ADDF764</gtr:id><gtr:title>Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75deba4059a8a10a422147d5bef9b2e2"><gtr:id>75deba4059a8a10a422147d5bef9b2e2</gtr:id><gtr:otherNames>Smith SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545ceccee61404.73349728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>500C58B4-7BDE-4BD1-861B-4034852A5A44</gtr:id><gtr:title>Identification, cloning and characterisation of interleukin-1F5 (IL-36RN) in the chicken.</gtr:title><gtr:parentPublicationTitle>Developmental and comparative immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd522259e84925019b4209a0b5f48c7"><gtr:id>3dd522259e84925019b4209a0b5f48c7</gtr:id><gtr:otherNames>Gibson MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0145-305X</gtr:issn><gtr:outcomeId>56b38079eb9704.20381682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2337B638-19B7-45A3-BA25-56887264AD57</gtr:id><gtr:title>The chicken IL-1 family: evolution in the context of the studied vertebrate lineage.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd522259e84925019b4209a0b5f48c7"><gtr:id>3dd522259e84925019b4209a0b5f48c7</gtr:id><gtr:otherNames>Gibson MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>545ceccebf0351.77628340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83792008-FAE8-4C18-B900-E2D60385D878</gtr:id><gtr:title>Development of a high density 600K SNP genotyping array for chicken.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cec11b7cc49221e1a5f74073c9cecc7"><gtr:id>7cec11b7cc49221e1a5f74073c9cecc7</gtr:id><gtr:otherNames>Kranis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545cecce4d8b48.75217228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50CAA139-6EA8-457E-9B1A-DDBAF80D4067</gtr:id><gtr:title>Large scale variation in DNA copy number in chicken breeds.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0b960a665d4b8dd29d3f7be51ddc0b9"><gtr:id>d0b960a665d4b8dd29d3f7be51ddc0b9</gtr:id><gtr:otherNames>Crooijmans RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545cecce734b91.89064449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5893D7E2-6A42-4F0B-BC22-05509F7E66EE</gtr:id><gtr:title>Meta-analysis of chicken--salmonella infection experiments.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b879358f5cfe98175f9a101ee68f9fed"><gtr:id>b879358f5cfe98175f9a101ee68f9fed</gtr:id><gtr:otherNames>Te Pas MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545cecce9b2321.02662975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7A80D53-B9DD-469F-AEDC-1B6122D11D16</gtr:id><gtr:title>A maximum likelihood QTL analysis reveals common genome regions controlling resistance to Salmonella colonization and carrier-state.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56c854be7181c9736a3e414273dfc849"><gtr:id>56c854be7181c9736a3e414273dfc849</gtr:id><gtr:otherNames>Thanh-Son T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545cecce290cf8.47024984</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/I/00001712</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>